Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference

Stock Information for Immuron Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Immuron Limited

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target
Immuron Reports HY26 Results and Strategic Reset
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
Immuron Reports Continued Sales Growth
Immuron New U.S. Department of Defense Award & Clinical Trial Update
Immuron IMM-529 IND approved by FDA
Immuron Announces Clinical Trial Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.